Converting from oral morphine to subcutaneous diamorphine

Hanks GW , de Conno F , Ripamonti C et al. Morphine in cancer pain: modes of administration. Br Med J 1996; 312: 823–826.

Twycross RG , Lack SA eds. Symptom control in far advanced cancer: pain relief. London: Pitman, 1983: 190–199.

Twycross RG . The equipotent dose ratio of diamorphine and morphine administered by mouth. Br J Pharmacol 1972; 46: 554–555P.

Twycross RG . Choice of strong analgesic in terminal cancer: diamorphine or morphine? Pain 1977; 3: 93–104.

Beaver WT , Schein PS , Hext M . Comparison of the analgesic effect of intramuscular heroin and morphine in patients with cancer pain. Clin Pharmacol Ther 1981; 29: 232.

Kaiko RF , Wallenstein SL , Rogers AG , Grabinski PY , Houde RW . Analgesic and mood effects of heroin and morphine in cancer patients with postoperative pain. New Engl J Med 1981; 304: 1501–1505.

Levine MN , Sackett DL , Bush H . Heroin vs morphine for cancer pain? Arch Intern Med 1986; 146: 353–356.

Hanks GW , Hoskin PJ . Opioid analgesics in the management of pain in patients with cancer. A review. Palliat Med 1987; 1: 1–25.

Twycross RG , Wilcock A , Thorp S . Palliative care formulary. Abingdon: Radcliffe Medical Press, 1998: 114.

Kaye P . A to Z of hospice and palliative medicine. Northampton: EPL Publications, 1994: 227.

Hanks G , Cherny C . Opioid analgesic therapy. In: Doyle D , Hanks G , MacDonald N eds. Oxford textbook of palliative medicine, 2nd edn. Oxford: Oxford University Press, 1998: 338.